Global Cell Based Assays Market, By Type (Cell Viability Assay, Cytotoxicity Assay, Cell Death Assay, Cell Proliferation Assay and Others), Product and Services (Consumables, Services, Instruments and Software), Technology (Flow Cytometry, High Throughput Screening, High Content Screening and Label Free Detection), Application (Drug Discovery, Basic Research, Others), End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutions, Government Organizations, Others), Distribution Channel (Direct, Indirect) – Industry Trends and Forecast to 2029.
Global Cell Based Assays Market Analysis and Size
Over the years, the market has seen notable improvements of cell based assay due to the innovations in technologically advanced products and rising research and development expenditure on research. The market is projected to expand substantially over the forecasted period.
- Global cell based assays market was valued at USD 18.9 billion in 2021 and is expected to reach USD 32.96 billion by 2029, registering a CAGR of 7.2% during the forecast period of 2022-2029. The "drug discovery" accounts for the largest application segment in the cell based assays market within the forecasted period owing to an increase in the research and development investment by biopharmaceutical companies. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Global Cell Based Assays Market Definition
Cell-based assays are a technique used for cytotoxic and biological testing of medicinal products, such as potency and mechanism of action. It is a homogenous approach for determining the quantity of live and dead cells in a sample. Cell-based assays are used to analyze living cells using various characteristics such as pharmacokinetics and pharmacodynamics. Cell-based assays have evolved into a flexible tool in healthcare research and development, particularly in investigations aimed at understanding specific cell functions, such as antibody function or therapeutic efficacy on a set of cells.
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2019 - 2014)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
By Type (Cell Viability Assay, Cytotoxicity Assay, Cell Death Assay, Cell Proliferation Assay and Others), Product and Services (Consumables, Services, Instruments and Software), Technology (Flow Cytometry, High Throughput Screening, High Content Screening and Label Free Detection), Application (Drug Discovery, Basic Research, Others), End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutions, Government Organizations, Others), Distribution Channel (Direct, Indirect)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa
|
|
Market Players Covered
|
Danaher (U.S), Thermo Fisher Scientific (US), Merck KGaA (Germany), BD (U.S), GE (U.S), PerkinElmer, Inc. (U.S), Promega Corporation (U.S), Charles River Laboratories (U.S), Cell Signaling Technology, Inc. (U.S), Lonza (Switzerland), BioAgilytix Labs (US), Cisbio (U.S), Reaction Biology (U.S), Lebermuth, Inc. (U.S), Eurofins DiscoverX Products (U.S), and AAT Bioquest, Inc. (U.S)
|
Cell Based Assays Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:
Drivers
-
Growing Preference for Cell-Based Assays
They offer consistent tissue-specific responses in a biologically relevant microenvironment as opposed to biochemical assays. Moreover, owing to their lead identification and optimization procedures in drug development, the pharmaceutical and biotechnology firms are adopting the cell based assays, which is the most significant factor driving the growth for this market.
Furthermore, the increased risk of disease outbreaks (such as swine flu, COVID-19) and growth in the number of research activities are also expected to fuel market growth. The low labor and raw material costs and the growing number of CROs providing drug discovery services are also projected to cushion the market's growth.
Moreover, the technological advancements in the end-use sectors for cell-based assays and the introduction of new drugs are estimated to generate lucrative opportunities for the market. Growth in drug discovery projects and the adoption of strategic approaches such as collaborations to develop drug candidates will further expand the cell based assays market's growth rate in the future.
Restraints/Challenges Global Cell Based Assays Market
-
High Costs of Instruments
The overall cost of production of biopharmaceuticals has increased considerably due to the use of these expensive systems. The high price of the instrumentation will reduce the return on investments (ROI) owing to low adaptation, which is expected to obstruct market growth.
-
Dearth of Professionals
Also, the shortage of skilled professionals is projected to challenge the cell based assays market in the forecast period of 2022-2029.
This cell based assays market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the cell based assays market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Post Covid-19 Impact on Cell Based Assays Market
The cell based assays market was moderately impacted by the outbreak of COVID-19. Even though there were imposition of the government's lockdown and social distancing restrictions to curb the COVID-19 pandemic outbreak, the vaccine-related research in pharmaceutical and biotechnological firms, research centers, and university research institutions is regarded critical, and operations and production have been significantly unaffected. The functional efficiency of the antibodies generated to neutralise the target virus is assessed for both vaccinations and treatments. Cell-based assays are used to reduce the time and boost the throughput of these experiments. As a result, the need for cell-based tests to offer an early indication of the toxicity features of drug candidates has skyrocketed.
The availability of research funds and the demand for and manufacture of cell-based test products are predicted to expand as a result of the increased research activity. The rising need for COVID-19 research has provided a wide scope for cell-based 45 tests in viral infection research, vaccine development, and overall drug discovery.
Recent Developments
- In December 2020, Phitonex, Inc., a company that has pioneered a spectral dye platform for high-resolution biology applications designed to accelerate research and development in cell therapy, immuno-oncology, and immunology research, has been acquired by Thermo Fisher Scientific, the world leader in serving science. Thermo Fisher will be able to offer more flow cytometry and imaging multiplexing capabilities thanks to Phitonex's product offering, which will help them meet changing customer needs in protein and cell analysis research.
Global Cell Based Assays Market Scope
The cell based assays market is segmented on the basis of type, product and services, technology, application, end user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Cell Viability Assay
- Cytotoxicity Assay
- Cell Death Assay
- Cell Proliferation Assay
- Others
On the basis of type, the cell based assays market is segmented into cell viability assay, cytotoxicity assay, cell death assay, cell proliferation assay and others.
Product and Services
- Consumables
- Services
- Instruments
- Software
On the basis of product and services, the cell based assays market is segmented into consumables, services, instruments and software. The consumables are sub-segmented into reagents and assay kits. Assay kits are also further sub-segmented into reporter gene assays, cell growth assays, second messenger assays, cell death assays and other assay kits. The instruments are sub-segmented into microplates, microplate reader, high throughput screening and liquid handling systems.
Technology
- Flow Cytometry
- High Throughput Screening
- High Content Screening
- Label Free Detection
On the basis of technology, the cell based assays market is segmented into flow cytometry, high throughput screening, high content screening and label free detection.
Application
- Drug Discovery
- Basic Research
- Others
On the basis of application, the cell based assays market is segmented into drug discovery, basic research and others. Drug discovery will be sub-segmented into toxicity studies, pharmacodynamics studies and pharmacokinetic studies. The drug discovery is projected to register high growth owing to the increase in the research and development investment by biopharmaceutical companies.
End User
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations
- Academic and Research Institutions
- Government Organizations
- Others
On the basis of end user, the cell based assays market is bifurcated into pharmaceutical and biotechnology companies, contract research organizations, academic and research institutions, government organizations and others.
Distribution Channel
- Direct
- Indirect
On the basis of distribution channel, the cell based assays market is bifurcated into direct and indirect.
Cell Based Assays Market Regional Analysis/Insights
The cell based assays market is analyzed and market size insights and trends are provided by country, type, product and services, technology, application, end user and distribution channel as referenced above.
The countries covered in the cell based assays market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the cell based assays market because of the increase in awareness about these assays for drug discovery along with the fast-paced growth in development and use of cell-based assays within the region. Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the adoption of strategic approaches such as collaborations to develop drug candidates, increasing research and developments investment by the government, and growing infrastructural development within the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The cell based assays market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for cell based assays market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the cell based assays market. The data is available for historic period 2010-2020.
Competitive Landscape and Cell Based Assays Market Share Analysis
The cell based assays market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to cell based assays market.
Some of the major players operating in the cell based assays market are Danaher (U.S), Thermo Fisher Scientific (US), Merck KGaA (Germany), BD (U.S), GE (U.S), PerkinElmer, Inc. (U.S), Promega Corporation (U.S), Charles River Laboratories (U.S), Cell Signaling Technology, Inc. (U.S), Lonza (Switzerland), BioAgilytix Labs (US), Cisbio (U.S), Reaction Biology (U.S), Lebermuth, Inc. (U.S), Eurofins DiscoverX Products (U.S), and AAT Bioquest, Inc. (U.S) among others.
Research Methodology : Global Cell Based Assays Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-cell-based-assays-market
SKU-